Impact of pretransplant blinatumomab on post-transplant outcomes in B-cell acute lymphoblastic leukemia: a systematic review and meta-analysis
{{output}}
Background: B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematological malignancy that often requires allogeneic hematopoietic cell transplant (HCT) for long-term remission. Outcomes after HCT are affected by pre-... ...
